Back to Search Start Over

Gastroenteritis aggressive versus slow treatment for rehydration (GASTRO): a phase II rehydration trial for severe dehydration: WHO plan C versus slow rehydration

Authors :
Kirsty A. Houston
Jack Gibb
Peter Olupot-Olupot
Nchafatso Obonyo
Ayub Mpoya
Margaret Nakuya
Rita Muhindo
Sophie Uyoga
Jennifer A. Evans
Roisin Connon
Diana M. Gibb
Elizabeth C. George
Kathryn Maitland
Source :
BMC Medicine, Vol 17, Iss 1, Pp 1-14 (2019)
Publication Year :
2019
Publisher :
BMC, 2019.

Abstract

Abstract Background World Health Organization rehydration management guidelines (plan C) for severe dehydration are widely practiced in resource-poor settings, but never formally evaluated in a trial. The Fluid Expansion as a Supportive Therapy trial raised concerns regarding the safety of bolus therapy for septic shock, warranting a formal evaluation of rehydration therapy for gastroenteritis. Methods A multi-centre open-label phase II randomised controlled trial evaluated two rehydration strategies in 122 Ugandan/Kenyan children aged 60 days to 12 years with severe dehydration secondary to gastroenteritis. We compared the safety and efficacy of standard rapid rehydration using Ringer’s lactate (100 ml/kg over 3 h (6 h if − 1 year respectively) versus 10.4 ml/kg (6.6) in slow arm. By 8 hours volume received were similar mean (SD) plan C: 96.3 ml/kg (15.6) and 97.8 ml/kg (10.0) for children < 1 and ≥ 1 year respectively vs 93.2 ml/kg (12.2) in slow arm. By 48-h, three (5%) plan C vs two (3%) slow had an SAE (risk ratio 0.67, 95% CI 0.12–3.85, p = 0.65). There was no difference in time to the correction of dehydration (p = 0.9) or time to discharge (p = 0.8) between groups. Atrial natriuretic peptide levels rose substantially by 8 hours in both arms, which persisted to day 7. Day 7 weights suggested only 33 (29%) could be retrospectively classified as severely dehydration (≥ 10% weight loss). Conclusion Slower rehydration over 8 hours appears to be safe, easier to implement than plan C. Future large trials with mortality as the primary endpoint are warranted. Trial registration ISRCTN67518332. Date applied 31 August 2016.

Details

Language :
English
ISSN :
17417015
Volume :
17
Issue :
1
Database :
Directory of Open Access Journals
Journal :
BMC Medicine
Publication Type :
Academic Journal
Accession number :
edsdoj.499ab93621a14bbaa540616461ed0198
Document Type :
article
Full Text :
https://doi.org/10.1186/s12916-019-1356-z